Changing rate of non-B subtypes and coinfection with hepatitis B/C viruses in newly diagnosed HIV type 1 individuals in Spain

AIDS Research and Human Retroviruses

Volumn 27, Issue 6, 2011, Pages 633-638

  Treviño, Ana ^a   Soriano, Vincent ^a   Rodríguez, Carmen ^b   Arredondo, Miguel ^a   Rivas, Pablo ^a   Herrero Mendoza, Dolores ^a   Parra, Patricia ^a   Del Romero, Jorge ^b   Anta, Lourdes ^a   Puente, Sabino ^a   De Mendoza, Carmen ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b CENTRO SANITARIO SANDOVAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; PRIORITY JOURNAL; SPAIN; VIRUS DETECTION;

ADULT; COMORBIDITY; ENDEMIC DISEASES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; MALE; PREVALENCE; SPAIN;

EID: 79957603478     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0247     Document Type: Article

References (23)

1. McCutchan F: Global epidemiology of HIV. J Med Virol 2006;78(Suppl 1):7-12
2. Plantier J, Leoz M, Dickerson J, et al.: A new human immunodeficiency virus derived from gorillas. Nat Med 2009; 15:871-872
3. Wertheim J and Worobey M: Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2 PLoS Comput Biol 2009;5:e1000377
4. HIV sequence database: New Mexico: Los Alamos Nacional Laboratory. Available from .
5. Taylor B and Hammer S: The challenge of HIV-1 subtype diversity. N Engl J Med 2008;359:1965-1966
6. Geretti AM: HIV-1 subtypes: Epidemiology and significance for HIV management. Curr Opin Infect Dis 2006;19:1-7 (Pubitemid 43032432)
7. Tatt I, Barlow K, Clewley J, Gill O, and Parry J: Surveillance of HIV-1 subtypes among heterosexuals in England and Wales, 1997-2000 J Acquir Immune Defic Syndr 2004;36: 1092-1099 (Pubitemid 38989376)
8. Semaille C, Barin F, Cazein F, et al.: Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: Experience after 2 years in France. J Infect Dis 2007;196:377-383 (Pubitemid 47093888)
9. Holguín A, de Mulder M, Yebra G, López M, and Soriano V: Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. Curr HIV Res 2008;6:327-334
10. Stanford University HIV Drug Resistance Database Team: Sierra: The Stanford HIV Web Service (Beta Version). http://hivdb.-stanford.edu/pages/ webservices/. Accessed 11 June 2010
11. Alcantara L, Cassol S, Libin P, et al.: A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res 2009;37:634-642
12. Leitner T, Korber B, Daniels M, Calef C, and Foley B: HIV-1 subtype and circulating recombinant form (CRF) reference sequences, 2005 In: HIV Sequence Compendium 2005 (Leitner T, Foley B, Hahn B, Marx P, McCutchan F, Mellors J, et al., Eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2005 pp. 41-48
13. Poveda E, de Mendoza C, Parkin N, et al.: Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes. AIDS 2008;22:611-616 (Pubitemid 351674068)
14. De Mendoza C, Garrido C, Poveda E, et al.: Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain. AIDS Res Hum Retroviruses 2009; 25: 967-972
15. Taylor B and Hammer S: The challenge of HIV-1 subtype diversity. N Engl J Med 2008;359:1965-6
16. Holguín A, Pena MJ, Troncoso F, and Soriano V: Introduction of non-B subtypes among Spaniards newly diagnosed with HIV type 1 in the Canary Islands. AIDS Res Hum Retroviruses 2007;23:498-502 (Pubitemid 46700881)
17. Semaille C, Cazein F, Pillonel J, et al.: Four years of surveillance of recent HIV infections at country level, France, mid 2003-2006: Experience and perspectives. Euro Surveill 2008;13:145-153
18. Wheeler W, Ziebell R, Zabina H, et al.: Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, US-2006 AIDS 2010;24: 1203-1212
19. Konopnicki D, Mocroft A, de Wit S, et al.: Hepatitis B and HIV: Prevalence, AIDS progression, response to HAART and increased mortality in the EuroSIDA cohort. AIDS 2005; 19:2117-2125
20. Soriano V, Puoti M, Peters M, et al.: Care of HIV patients with chronic hepatitis B: Updated recommendations from the HIV-HBV International panel. AIDS 2008;22:1399-1410
21. Thio C and Locarnini S: Treatment of HIV/HBV coinfection: Clinical and virologic issues. AIDS Rev 2007;9:40-53 (Pubitemid 46730282)
22. Madhava V, Burgess C, and Drucker E: Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002;2:293-302 (Pubitemid 34464740)
23. Soriano V, Vispo E, Labarga P, Medrano J, and Barreiro P: Viral hepatitis and HIV co-infection. Antiviral Res 2010;85: 303-315